Johnson & Johnson Announces Submission to World Health Organization for Emergency Use Listing of Investigational Single-Shot Janssen COVID-19 Vaccine Candidate Medical Device Investing
Bristol Myers Squibb Announces Early Participation Results and Early Settlement of Tender Offers for Up to an Aggregate Purchase Price of Up to $4.0 Billion Biotech Investing
Lobe Sciences Successfully Completes Proof-of-Concept of Proprietary Nasal Mist Device Cannabis Investing News
Numinus announces milestones in compassionate access trial for MDMA-assisted therapy in collaboration with MAPS Public Benefit Corporation Cannabis Investing News
Aurinia Pharmaceuticals to Present at the SVB Leerink 10th Annual Global Healthcare Conference Biotech Investing
Myovant Sciences and Pfizer Announce Publication in the New England Journal of Medicine of Phase 3 LIBERTY Studies of Once-Daily Relugolix Combination Therapy in Women with Uterine Fibroids Pharmaceutical Investing
Imcyse Raises Additional EUR 21.3 Million in Series B Financing Round - Pfizer Joins as Newest Shareholder Pharmaceutical Investing
Independent Data Monitoring Committee Concludes OlympiA Trial of LYNPARZA® Crossed Superiority Boundary for Invasive Disease-Free Survival vs. Placebo at Planned Interim Analysis Pharmaceutical Investing
